Vijaya Diagnostic Centre Limited (VIJAYA.BO)
INR 1059.65
(-1.01%)
INR 1059.65
(-1.01%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.2 Billion INR | 12.6% |
| 2022 | 1.95 Billion INR | -9.4% |
| 2021 | 2.16 Billion INR | 23.0% |
| 2020 | 1.77 Billion INR | 28.97% |
| 2019 | 1.47 Billion INR | 22.31% |
| 2018 | 1.18 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 612.37 Million INR | -2.35% |
| 2023 Q1 | 538.25 Million INR | 0.37% |
| 2023 Q2 | 641.16 Million INR | 19.12% |
| 2023 Q3 | 574.15 Million INR | -10.45% |
| 2023 FY | - INR | 12.6% |
| 2023 Q4 | 631.09 Million INR | 9.92% |
| 2022 Q1 | 426.62 Million INR | -14.35% |
| 2022 FY | - INR | -9.4% |
| 2022 Q4 | 536.25 Million INR | 12.08% |
| 2022 Q3 | 478.43 Million INR | -8.07% |
| 2022 Q2 | 520.46 Million INR | 21.99% |
| 2021 Q2 | 543.02 Million INR | -9.71% |
| 2021 FY | - INR | 23.0% |
| 2021 Q4 | 498.12 Million INR | -2.39% |
| 2021 Q3 | 510.31 Million INR | -6.02% |
| 2021 Q1 | 601.39 Million INR | 5.71% |
| 2020 Q1 | 157.37 Million INR | 0.0% |
| 2020 Q2 | 536.58 Million INR | 240.97% |
| 2020 Q3 | 494.16 Million INR | -7.91% |
| 2020 FY | - INR | 28.97% |
| 2020 Q4 | 568.89 Million INR | 15.12% |
| 2019 FY | - INR | 22.31% |
| 2018 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 1.61 Billion INR | -37.169% |
| Dr. Lal PathLabs Limited | 6.78 Billion INR | 67.426% |
| Metropolis Healthcare Limited | 2.96 Billion INR | 25.621% |
| Thyrocare Technologies Limited | 1.48 Billion INR | -49.125% |
| Vimta Labs Limited | 906.39 Million INR | -143.713% |